Page last updated: 2024-10-18

ethanolamine and Myocardial Ischemia

ethanolamine has been researched along with Myocardial Ischemia in 1 studies

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research Excerpts

ExcerptRelevanceReference
"In trimetazidine-treated cells, arachidonic acid incorporation was increased in the phospholipid, but not in other lipid fractions."1.30Is the cytoprotective effect of trimetazidine associated with lipid metabolism? ( Grynberg, A; Lucien, A; Sentex, E; Sergiel, JP, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sentex, E1
Sergiel, JP1
Lucien, A1
Grynberg, A1

Other Studies

1 other study available for ethanolamine and Myocardial Ischemia

ArticleYear
Is the cytoprotective effect of trimetazidine associated with lipid metabolism?
    The American journal of cardiology, 1998, Sep-03, Volume: 82, Issue:5A

    Topics: Animals; Cells, Cultured; Choline; Chromatography, Gas; Ethanolamine; Fatty Acids; Inositol; Linolei

1998